No profile data available.
IM Cannabis Corp. (IMCC) is an essential consumer products company in the marijuana product manufacturing industry, based in Vancouver, Canada, with about 44 full-time employees.
It reported revenue of 54.73 million CAD for fiscal year 2025, up 1.3% from fiscal year 2024, and net income of -11.32 million CAD. Its market capitalization was $3.20 million as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 5, 2026.
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
IM Cannabis reported 54.73 million CAD in revenue for fiscal year 2025, up 1.3% from 54.03 million CAD in fiscal year 2024.
$3.20 million as of October 5, 2026.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include SciSparc Ltd. (SPRC), Panacea Life Sciences Holdings, Inc. (PLSH), Akanda Corp. (AKAN), Suncliff, Inc. (SCLF).